Alendronate for seconcary prevention of osteoporotic fractures

Published by Ilkka Kunnamo on Sep 16, 2018

Disclaimer

Sponsors

Contact

Abstract

SOF for Health Benefit Analysis

Language

en

PICOS

PICO 1.1

Population
Alendronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women
Intervention
Alendronate 10 mg
Comparator
Control - 3 years baseline denominators
Outcomes

PICO 1.2

Population
Alendronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women
Intervention
Alendronate 10 mg
Comparator
Control - all years baseline denominators
Outcomes